Abstract:Alzheimer's disease (AD) is the most common neurodegenerative disorder accompanied with memory impairment followed by global cognitive deficits. Accumulation of beta–amyloid peptide 42 (Aβ42) in the brain is widely believed to be central etiology of AD. However, the precise molecular mechanisms underlying neuronal injury and death caused by Aβ42 remain to be elucidated. In vitro, Aβ42 can form a wide array of structures, including multiple monomer conformers, various size of oligomers, Aβ–derived diffusible ligands (ADDLs), protofibrils, fibrils and spheroids. Recent research efforts have been focused on understating the relationship between these different misfolding structures and neurotoxicity and the relevance to AD pathogenesis. In previous work, we have reported that the transgenic flies expressing Aβ42 fused to secretion signal in neurons showed progressive amyloid deposits formation, learning defects and neurodegeneration. Our recent study using immuno–electron microscopy further confirmed that most of Aβ42 accumulation occurred intraneuronally. These results indicate our Aβ42 fly is a useful model system to study intraneuronal toxicity of Aβ42 in vivo. To gain insights into structure–toxicity relationship of Aβ42 in vivo, we established new transgenic fly lines expressing Aβ42 with mutations that either accelerate or inhibit aggregation of Aβ42 in vitro including familial Arctic mutation. We found that Aβ42 with Arctic mutation accumulated in neuronal soma and caused cell body degeneration. In contrast, the mutant Aβ42 that is known to reduce Aβ42 aggregation in vitro accumulated in dendrites and induced neurite degenetarion. Interestingly, wild–type Aβ42 accumulated in both neuronal soma and dendrites, indicating that each mutant Aβ42 may represent one aspect of wild type Aβ42. In addition to different neuronal injury, such as cell death and neurite degeneration, expression of mutant Aβ42 caused different magnitude of locomotor impairment and premature death. We are currently analyzing their effects on learning and memory. These results suggest that each misfolding status of Aβ42 is associated with a specific type of neuronal injury, and raise the possibility that pathologies induced by Aβ42 include multiple mechanisms caused by different misfolding status.

P1-028: Overexpression of neprilysin reduces Abeta42-induced neuron loss and intraneuronal Abeta42 deposits, but causes age-dependent axon pathology in drosophila

Overexpression of Neprilysin Reduces Alzheimer Amyloid-Beta42 (Abeta42)-Induced Neuron Loss and Intraneuronal Abeta42 Deposits but Causes a Reduction in Camp-Responsive Element-Binding Protein-Mediated Transcription, Age-Dependent Axon Pathology, and Premature Death in Drosophila.

Neprilysin: an Enzyme Candidate to Slow the Progression of Alzheimer'S Disease

Neprilysin Protects Neurons Against Aβ Peptide Toxicity

Dynamic Alteration of Neprilysin and Endothelin-Converting Enzyme in Age-Dependent Appswe/Ps1de9 Mouse Model of Alzheimer'S Disease

P2-296: Enhanced Proteolysis of Aβ Peptide Reduces Tau Phosphorylation and Neurofibrillary Tangle Formation in APP/tau Transgenic Mice

Dynamic alteration of neprilysin and endothelin-converting enzyme in age-dependent APPswe/PS1dE9 mouse model of Alzheimer's disease.

Linking aβ42-induced hyperexcitability to neurodegeneration, learning and motor deficits, and a shorter lifespan in an Alzheimer's model.

Lipophorin Receptors Genetically Modulate Neurodegeneration Caused by Reduction of Psn Expression in the Aging Drosophila Brain

P1–006: Distinct Accumulation Properties of Aβ42 in the Brain Are Associated with Specific Pathological Phenotypes in Drosophila

Intraneuronal Accumulation of Aβ42 Induces Age-Dependent Slowing of Neuronal Transmission in Drosophila

Expression of beta-amyloid induced age-dependent presynaptic and axonal changes in Drosophila

Dissecting the Pathological Effects of Human Aβ40 and Aβ42 in Drosophila : A Potential Model for Alzheimer's Disease

Dissecting The Pathological Effects Of Human A Beta 40 And A Beta 42 In Drosophila: A Potential Model For Alzheimer'S Disease

Expression of Neprilysin in Skeletal Muscle by Ultrasound-Mediated Gene Transfer (Sonoporation) Reduces Amyloid Burden for AD.

Expression and Functional Profiling of Neprilysin, Insulin‐degrading Enzyme, and Endothelin‐converting Enzyme in Prospectively Studied Elderly and Alzheimer’s Brain

Hypoxia-induced down-regulation of neprilysin by histone modification in mouse primary cortical and hippocampal neurons.

Effects of HNE‐modification Induced by Aβ on Neprilysin Expression and Activity in SH‐SY5Y Cells

Estrogen Regulation of the Neprilysin Gene Through A Hormone-Responsive Element

Levels of Amyloid Beta (Aβ) Expression in the Caenorhabditis elegans Neurons Influence the Onset and Severity of Neuronally Mediated Phenotypes

Age-dependent alterations in the presynaptic active zone in a Drosophila model of Alzheimer's disease.